AA
NUVB.WS

AQR Arbitrage’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History

AQR Arbitrage’s Portfolio NUVB.WS Stock Details NUVB.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-16,666
Closed -$44K – 1159
2021
Q1 		$44K Buy
+16,666
New +$48.2K ﹤0.01% 910

Other funds holding NUVB.WS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

AQR Arbitrage's NUVB.WS Position: Q2 2021 in Review

AQR Arbitrage sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q2 2021, closing a stake of 16,666 shares — an estimated $44K sold.

AQR Arbitrage first reported a position in NUVB.WS in Q1 2021 and held it in 1 quarter. The position peaked at $44K in Q1 2021. 23 funds tracked by Wall St. Rank hold NUVB.WS as of Q2 2021.

  • AQR Arbitrage reported no remaining Nuvation Bio Inc Warrants position as of Q2 2021 after selling out during the quarter.
  • AQR Arbitrage sold 16,666 Nuvation Bio Inc Warrants shares in Q2 2021, an estimated $44K.
  • AQR Arbitrage first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 1 quarter.
  • AQR Arbitrage's Nuvation Bio Inc Warrants position peaked at $44K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q2 2021.

Based on AQR Arbitrage's 13F filing for Q2 2021, filed 16 Aug 2021.